AnaptysBio-Tesaro trial heads to post-trial briefs, argument set for Oct. 20
ANAB•Trial and briefing timeline
The consolidated trial ran July 14-17, 2026; opening brief is due Aug. 21, defense brief due Sept. 25, reply due Oct. 9.
Post-trial argument is scheduled for Oct. 20, 2026.
Post-trial schedule set in Delaware Chancery dispute
AnaptysBio disclosed post-trial briefing dates in its Delaware Chancery Court dispute with Tesaro and parent GlaxoSmithKline over a collaboration license.
The company seeks a declaration that Tesaro materially breached the agreement, alleging GlaxoSmithKline tortiously interfered.
